S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ALBPS

Biophytis (ALBPS)

Biophytis

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:ALBPS

Date	Time	Source	Headline	Symbol	Company
16/12/2023	09:07	Dow Jones News	ADRs Close Lower; Fanhua Slips 16%	EU:ALBPS	Biophytis
21/07/2023	03:21	Dow Jones News	Biophytis Shares Drop 11% After Request for Meeting With FDA on Covid-19 Treatment	EU:ALBPS	Biophytis
07/10/2021	08:00	GlobeNewswire Inc.	Biophytis to Restate Previously Issued Financial Statements	EU:ALBPS	Biophytis
03/07/2020	01:02	GlobeNewswire Inc.	Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patien...	EU:ALBPS	Biophytis
29/06/2019	02:29	GlobeNewswire Inc.	Biophytis Announces Results of 2019 Annual General Meeting of Shareholders	EU:ALBPS	Biophytis
13/06/2019	22:23	GlobeNewswire Inc.	Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon)	EU:ALBPS	Biophytis
08/06/2019	04:13	GlobeNewswire Inc.	Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer	EU:ALBPS	Biophytis
23/05/2019	04:55	GlobeNewswire Inc.	Biophytis Announces Publication of its 2018 Annual Report	EU:ALBPS	Biophytis
23/05/2019	00:31	GlobeNewswire Inc.	Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States	EU:ALBPS	Biophytis
12/03/2019	13:00	GlobeNewswire Inc.	Biophytis Reports Annual 2018 Financial Results and Provides Operational Update	EU:ALBPS	Biophytis
18/02/2019	17:00	GlobeNewswire Inc.	Biophytis Announces Three Oral and One Poster Presentations at the 2019 International Conference on Frailty and Sarcopenia Re...	EU:ALBPS	Biophytis
16/05/2018	18:35	Cercle Finance	Biophytis: statut de médicament orphelin pour Sarconeos	EU:ALBPS	Biophytis
21/11/2017	00:55	Cercle Finance	Biophytis: dans le vert sur un relèvement d'analyste.	EU:ALBPS	Biophytis
01/11/2017	19:22	Cercle Finance	Biophytis: conclusion d'accords pour une levée de fonds.	EU:ALBPS	Biophytis
30/10/2017	20:53	Cercle Finance	Biophytis: feu vert de la FDA pour l'étude SARA-INT.	EU:ALBPS	Biophytis
25/09/2017	19:13	Cercle Finance	Biophytis: demande d'IND auprès de la FDA.	EU:ALBPS	Biophytis
03/08/2017	16:34	Cercle Finance	Biophytis: nomination d'un directeur business development.	EU:ALBPS	Biophytis
04/04/2017	16:48	Cercle Finance	Biophytis: boucle le financement de l'étude SARA-INT.	EU:ALBPS	Biophytis
27/03/2017	18:33	Cercle Finance	Biophytis: ouverture des premiers centres pour SARA-OBS.	EU:ALBPS	Biophytis
02/03/2017	18:42	Cercle Finance	Biophytis: données favorables de l'étude SARA-PK.	EU:ALBPS	Biophytis
22/02/2017	19:06	Cercle Finance	Biophytis: emménage au sein de l'UPMC.	EU:ALBPS	Biophytis
06/01/2017	19:53	Cercle Finance	Biophytis: participation à la JPMorgan Healthcare.	EU:ALBPS	Biophytis
19/12/2016	19:23	Cercle Finance	Biophytis: présentations de données sur Sarconeos à Berlin.	EU:ALBPS	Biophytis
30/11/2016	17:32	Cercle Finance	Biophytis: succès de l'étude clinique SARA-PK pour Sarconeos	EU:ALBPS	Biophytis
22/11/2016	18:02	Cercle Finance	Biophytis: autorisations pour l'étude SARA-OBS.	EU:ALBPS	Biophytis
16/11/2016	01:52	Cercle Finance	Biophytis: quatre présentations à venir dans la sarcopénie.	EU:ALBPS	Biophytis
24/10/2016	17:00	Cercle Finance	Biophytis: accord avec Patheon pour des lots de Macuneos.	EU:ALBPS	Biophytis
11/10/2016	17:01	Cercle Finance	Biophytis: mise en place d'une plateforme d'e-santé.	EU:ALBPS	Biophytis
30/09/2016	17:33	Cercle Finance	Biophytis: pertes creusées au 1er semestre.	EU:ALBPS	Biophytis
22/09/2016	19:04	Cercle Finance	Biophytis: succès de la première phase d'une étude.	EU:ALBPS	Biophytis

Showing the most relevant articles for your search:EU:ALBPS

AUD vs US Dollar

JP Morgan Chase

Woodside Petroleum

Australian SE All Ordina...

National Australia Bank

Gold vs US Dollar

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions